A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.

Topics:  german   eli lilly    co   alimta   december   patent   
BING NEWS:
  • Eli Lilly lifts guidance after sales of Mounjaro and Zepbound drugs soar
    Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Soaring sales of Eli Lilly’s hugely popular diabetes and weight loss drugs Mounjaro and Zepbound prompted ...
    05/8/2024 - 12:32 am | View Link
  • Eli Lilly and Company (LLY)
    Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Monday, June 10, 2024, to discuss Eli Lilly and Co’s (NYSE ...
    05/7/2024 - 1:00 pm | View Link
  • Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
    Eli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock ...
    05/3/2024 - 10:26 pm | View Link
  • Analysts reveal Eli Lilly stock price targets after earnings
    The people at Eli Lilly (LLY) say they're working as fast as they can. The drugmaker, which reported first-quarter earnings on Tuesday, responded to concerns about supplies of two of its key ...
    05/2/2024 - 12:03 pm | View Link
  • What You Need To Know Ahead of Eli Lilly's Earnings Report
    Scott Olson / Staff / Getty Images Eli Lilly is set to report earnings Tuesday as investors and analysts expect weight-loss drug demand to continue boosting the company's revenue and profits.
    04/26/2024 - 9:43 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News